Table 1.
Demographic characteristics of patients with COVID-19.
| Study population | No. (%) |
|---|---|
| No. of patients | 151 |
| ≥60 | 98 (64.9%) |
| <60 | 53 (35.1%) |
| Gender | |
| Female | 65 (43.0%) |
| Male | 86 (57.0%) |
| Mean time of illness onset to admission, days | 18.4 ± 10.7 |
| Highest temperature ( ° C) | |
| ≥39.0 | 32 (21.2%) |
| <39.0 | 119 (78.8%) |
| Initial symptoms | |
| Fever | 95 (62.9%) |
| Cough | 78 (51.7%) |
| Dyspnea | 48 (31.8%) |
| Fatigue or myalgia | 33 (21.9%) |
| Digestive symptoms | 7 (4.6%) |
| Clinical classification | |
| Mild/Common | 29/60 (58.9%) |
| Severe/Critical | 50/12 (41.1%) |
| Therapy | |
| Antiviral | 96 (63.6%) |
| Antibiotic | 71 (47.0%) |
| Antioxidant | 34 (22.5%) |
| Hormone | 24 (15.9%) |
| Resochin | 14 (9.3%) |
| Clinical outcomes | |
| ICU admission | 21 (13.9%) |
| ARDS | 22 (14.6%) |
| Discharged | 131 (86.8%) |
| Died | 5 (3.3%) |
| Hospitalization | 15 (9.9%) |
Data are presented as n (%) or n/N (%), where N is the total number of patients in a group.
COVID-19, coronavirus disease 2019; ICU, intensive care unit; ARDS, acute respiratory distress syndrome.